55.98

1.28% -0.725

After Hours: 56.00 0.015 +0.03%

Tg Therapeutics Inc (TGTX)

Overview News Price History Option Chain Financials Why TGTX Down? Discussions Forecast Stock Split

Tg Therapeutics Inc stock is traded at $55.98, with a volume of 991.89K. It is down -1.28% in the last 24 hours and up +14.88% over the past month. TG Therapeutics Inc is a fully integrated, commercial-stage biotechnology company focused on acquiring, developing, and commercializing novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features.

Previous Close:

$56.71

Open:

$56.3

24h Volume:

991.89K

Relative Volume:

0.42

Market Cap:

$8.57B

Revenue:

$700.35M

Net Income/Loss:

$461.90M

P/E Ratio:

19.51

EPS:

2.8696

Net Cash Flow:

$-14.19M

1W Performance:

+3.81%

1M Performance:

+14.88%

6M Performance:

+91.80%

1Y Performance:

+75.56%

1-Day Range:

$55.56

$56.70

1-Week Range:

$52.11

$58.47

52-Week Range:

$26.76

$59.30

Tg Therapeutics Inc Stock (TGTX) Company Profile

Name

Tg Therapeutics Inc

Sector

Healthcare (1074)

Industry

Biotechnology (600)

Phone

(212) 554-4484

Address

2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY

Employee

399

Twitter

@TGTherapeutics

Next Earnings Date

2026-08-03

Latest SEC Filings

TGTX's Discussions on Twitter

Compare TGTX vs VRTX, REGN, ARGX, MRNA, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TGTX Tg Therapeutics Inc	55.98	7.74B	700.35M	461.90M	-14.19M	2.8696
VRTX Vertex Pharmaceuticals Inc	546.12	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	827.72	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,033.15	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	145.55	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	210.02	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Tg Therapeutics Inc Stock (TGTX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-06-25	Resumed	H.C. Wainwright	Buy
Jul-10-25	Resumed	Goldman	Neutral
Oct-29-24	Initiated	TD Cowen	Buy
Aug-02-23	Upgrade	Goldman	Sell → Neutral
Jun-26-23	Resumed	Jefferies	Buy
May-20-22	Initiated	BofA Securities	Underperform
Feb-23-22	Reiterated	B. Riley Securities	Buy
Nov-15-21	Downgrade	Goldman	Neutral → Sell
Apr-20-21	Initiated	Goldman	Neutral
Apr-19-21	Reiterated	H.C. Wainwright	Buy
Sep-01-20	Initiated	JP Morgan	Overweight
Aug-11-20	Reiterated	H.C. Wainwright	Buy
Jun-05-20	Initiated	Evercore ISI	Outperform
Jan-17-20	Reiterated	H.C. Wainwright	Buy
Nov-27-19	Resumed	B. Riley FBR	Buy
Feb-06-19	Resumed	Jefferies	Buy
Sep-25-18	Downgrade	Raymond James	Strong Buy → Outperform
Mar-09-18	Reiterated	B. Riley FBR, Inc.	Buy
Dec-01-17	Resumed	B. Riley FBR, Inc.	Buy
Nov-14-17	Resumed	H.C. Wainwright	Buy
Apr-25-17	Initiated	Jefferies	Buy
Mar-06-17	Reiterated	FBR & Co.	Outperform
Oct-06-16	Resumed	Brean Capital	Buy
May-27-16	Initiated	SunTrust	Buy
Dec-01-15	Initiated	FBR Capital	Outperform
Sep-09-15	Initiated	Raymond James	Strong Buy
Aug-12-15	Resumed	H.C. Wainwright	Buy
Jun-19-15	Reiterated	Brean Capital	Buy
Dec-11-14	Reiterated	ROTH Capital	Buy
Dec-10-14	Reiterated	ROTH Capital	Buy

View All

Tg Therapeutics Inc Stock (TGTX) Latest News

Aug 21, 2026

TGTX Stock On Track For Best Day In 3.5 Months Amid Fresh Buyout Rumors - TradingView

Aug 21, 2026

TGTX Stock Alert: What to Know as Takeover Rumors Swirl Around TG Therapeutics - Yahoo Finance

Aug 21, 2026

TG Therapeutics Stock Jumps as Investors Reassess Growth Outlook - Quiver Quantitative

Aug 21, 2026

TGTX Stock Whipsaws As BRIUMVI Growth Fuels Bold 2026 Outlook - StocksToTrade

Aug 21, 2026

TGTX Stock Whipsaws As Guidance Jumps And EPS Miss Hits - timothysykes.com

Aug 21, 2026

TG Therapeutics (TGTX) Shares Surge 7.2% Amid Acquisition Rumors, Valuation Remains a Key Focus - GuruFocus

Aug 21, 2026

TG Therapeutics (TGTX) Stock Climbs 4% Amid Positive Market Sent - GuruFocus

Aug 21, 2026

Speculation on TG Therapeutics (TGTX) Acquisition Sparks Valuati - GuruFocus

Aug 21, 2026

Why is TG Therapeutics stock rallying today? By Investing.com - Investing.com Canada

Aug 21, 2026

Aug 20, 2026

Price to book forward of TG Therapeutics, Inc. – BX:NKB2 - TradingView

Aug 20, 2026

Aug 19, 2026

TGTX Stock Rises On Wall Street Price Target Hike, New Schizophrenia Trial Launch - Stocktwits

Aug 19, 2026

Top Damora Therapeutics, Inc. Common Stock (DMRA) Competitors 2026 - MarketBeat

Aug 19, 2026

TG Therapeutics (NASDAQ:TGTX) Combines Strong Growth with a Breakout Setup - ChartMill

Aug 19, 2026

Aug 18, 2026

TGTX Stock Jumps 5% On Positive Early Data For At-Home BRIUMVI In Muscle Disease - Stocktwits

Aug 18, 2026

TGTX Stock Rises 29% in 3 Months: Here's What You Should Know - qz.com

Aug 18, 2026